Your browser doesn't support javascript.
loading
Uniform designed research on the active ingredients assembling of Chinese medicine prescription for anti-liver fibrosis / 中国中西医结合杂志
Chinese Journal of Integrated Traditional and Western Medicine ; (12): 58-63, 2010.
Artículo en Chino | WPRIM | ID: wpr-231589
ABSTRACT
<p><b>OBJECTIVE</b>To explore the method and significance for studying active anti-liver fibrosis ingredients consisted Chinese medicine compound prescription based on Chinese medicine theory.</p><p><b>METHODS</b>Optimized prescription was screened out, adopting uniform block design with 4-factor 8-level table and regression analysis, through applying the four known effective ingredients (cordyceps sinensis polysaccharide, salvianolic acid B, amygdaloside and gypenosides) of Fuzheng Huayu Capsule (FZHYC, a new Chinese medine anti-liver fibrosis drug) to two rat liver fibrosis models established separately by dimethylnitrosamine (DMN) and CCl4, and taking the liver content of hydroxyproline (Hyp) as the screen index. Then a further study for comparing and verifying the efficacy of the obtained optimized prescription was conducted on the two former models respectively by observing the changes of Hyp content in liver, serum ALT activity and fibrosis pathology after medication, controlled by the original FZHYC and the recipe assembled by all the four ingredients.</p><p><b>RESULTS</b>Two optimized prescriptions (OPA and OPB) were screened out separately in the studies conducted on the two models. Both of them were consisted of cordyceps sinensis polysaccharide, Amygdaloside and Gypenosides, but different in constituent ratio, i.e., the ratio in OPA was 60 80 50, and that in OPB, 20 160 50. Verifying study showed both OPA and OPA were significantly effective, with the efficacy equivalent to that of FZHYC (P>0.05). However, when they were used in combining with salvianolic acid B (the cutout ingredient in the screening), the efficacy lowered surely.</p><p><b>CONCLUSIONS</b>Uniform design is a valuable method in the compatibility research of Chinese Medicine drugs' composition. To assemble a new compound recipe reasonably based on the prescription of traditional compound recipe could make its effect equivalent to that of the original prescription. Ingredients or constituents in a prescription, either presented synergistic or antagonistic effects, are not randomly stacked together, and they should be orderly assembled in intrinsic rules of qualitative and quantitative changing.</p>
Asunto(s)
Texto completo: Disponible Índice: WPRIM (Pacífico Occidental) Asunto principal: Medicamentos Herbarios Chinos / Extractos Vegetales / Diseño de Fármacos / Análisis de Regresión / Ratas Wistar / Gynostemma / Usos Terapéuticos / Combinación de Medicamentos / Quimioterapia / Amigdalina Tipo de estudio: Estudio diagnóstico / Estudio pronóstico / Investigación cualitativa Límite: Animales Idioma: Chino Revista: Chinese Journal of Integrated Traditional and Western Medicine Año: 2010 Tipo del documento: Artículo

Similares

MEDLINE

...
LILACS

LIS

Texto completo: Disponible Índice: WPRIM (Pacífico Occidental) Asunto principal: Medicamentos Herbarios Chinos / Extractos Vegetales / Diseño de Fármacos / Análisis de Regresión / Ratas Wistar / Gynostemma / Usos Terapéuticos / Combinación de Medicamentos / Quimioterapia / Amigdalina Tipo de estudio: Estudio diagnóstico / Estudio pronóstico / Investigación cualitativa Límite: Animales Idioma: Chino Revista: Chinese Journal of Integrated Traditional and Western Medicine Año: 2010 Tipo del documento: Artículo